Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non‐erosive reflux disease
- 20 November 2003
- journal article
- website
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 18 (11-12) , 1091-1098
- https://doi.org/10.1046/j.1365-2036.2003.01768.x
Abstract
Background : The reason why less than one‐half of patients with gastro‐oesophageal reflux disease develop complicated reflux disease (ulcerative oesophagitis, oesophageal strictures and Barrett's oesophagus) and erosive reflux oesophagitis is not fully understood. Supine nocturnal oesophageal acid reflux is considered to be critically involved in this phenomenon, but reliable data are lacking. Aim : To clarify whether high levels of supine nocturnal oesophageal acid exposure are associated with complicated reflux disease. Methods : Ambulatory 24‐h oesophageal pH monitoring was performed in 220 patients with gastro‐oesophageal reflux disease (56 with complicated reflux disease, 76 with erosive reflux oesophagitis and 88 with non‐erosive reflux disease). The total, supine nocturnal and upright diurnal percentage acid reflux times were calculated. Results : The total percentage acid reflux time was significantly greater in complicated reflux disease than in either erosive reflux oesophagitis (P = 0.024) or non‐erosive reflux disease (P = 0.000). These differences were entirely due to a greater supine nocturnal percentage acid reflux time (P = 0.038 and P = 0.000, respectively), whereas no difference was observed in the upright diurnal percentage acid reflux time. Conclusions : Complicated reflux disease is characterized by high levels of supine nocturnal percentage acid reflux time. Prospective studies would be appropriate to clarify whether the normalization of this parameter is relevant to the effective management of this subset of patients with gastro‐oesophageal reflux disease.Keywords
This publication has 44 references indexed in Scilit:
- An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapyAlimentary Pharmacology & Therapeutics, 2002
- Definitions of reflux disease and its separation from dyspepsiaGut, 2002
- Omeprazole therapy decreases the need for dilatation of peptic oesophageal stricturesAlimentary Pharmacology & Therapeutics, 1999
- Morning versus evening dosing of lansoprazole 30 mg daily on twenty‐four‐hour intragastric acidity in healthy subjectsAlimentary Pharmacology & Therapeutics, 1996
- The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients.Alimentary Pharmacology & Therapeutics, 1996
- Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.Gut, 1996
- Morning or evening dosage of omeprazole for gastro‐oesophageal reflux disease?Alimentary Pharmacology & Therapeutics, 1995
- Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux diseaseDigestive Diseases and Sciences, 1994
- Patterns of acid reflux in complicated oesophagitis.Gut, 1987
- Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease.Gut, 1987